Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Share-Based Compensation Expense

The table below sets forth the line items where share-based compensation expense was recorded for the twelve months ended December 31:

	2023		2022		2021
Cost of goods sold	$	1,860	$	1,630	$	1,321
Selling, general and administrative expense		24,470		30,295		28,188
Research and development expense		4,581		4,362		3,696
Total share-based compensation expense	$	30,911	$	36,287	$	33,205

Schedule of Share-Based Compensation Expense by Type

The table below sets forth share-based compensation expense by type for the twelve months ended December 31:

	2023		2022		2021
Share grants		30,894		36,251		33,132
Stock options		17		36		73
Total share-based compensation expense	$	30,911	$	36,287	$	33,205

Summary of Nonvested Share Grants

The table below sets forth a summary of our non-vested share grants in 2023, 2022 and 2021:

Restricted Stock Grants	Shares			Weighted Average Grant Date Fair Value ($)		Aggregate Intrinsic Value
Nonvested at December 31, 2021		1,402			54.94
Granted		535			69.87
Vested		(614	)		45.96	$	46,633
Forfeited and other		(55	)		61.87
Nonvested at December 31, 2022		1,269			65.29	$	96,634
Granted		645			84.87
Vested		(643	)		54.20	$	59,701
Forfeited and other		(48	)		73.33
Nonvested at December 31, 2023		1,223			81.02	$	98,493

Schedule of Share Based Compensation Stock Options Activity

The table below sets forth a summary of activity in our stock option plan:

Stock Options	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding and exercisable at December 31, 2021		5			27.92		0.4	$	409
Exercised during 2022		(5	)		27.92		0.4	$	409
Outstanding and exercisable at December 31, 2022 and 2023, respectively		-